Biotinylated Human DLL3 Domain (311-492) Protein
Catalog No: DLL3-HB005
- Species
- Human
- Expression System
- HEK293
- Tag
- His, Avi
- Activity
- Activity verified
Product overview
Recombinant Biotinylated Human DLL3 Domain (311-492) Protein is expressed in HEK293 cells with a His tag and Avi tag at the C-terminus. It contains amino acid residues Val311-Leu492 (UniProt accession: Q9NYJ7-1).
Product Details
- Molecular Aliases
- Delta3; DLL3; Pudgy; SCDO1; SCDO1delta3
- Protein Length
- Val311-Leu492
- Expression System
- HEK293
- Theoretical Molecular Weight
- The protein has a predicted MW of 22.69 kDa. Due to glycosylation, the protein migrates to 25-30 kDa based on Bis-Tris PAGE result.
- Purity
- > 95% as determined by Bis-Tris PAGE
- Endotoxin
- Less than 1 EU per μg by the LAL method.
- Buffer / Formulation
- Lyophilized from 0.22 μm filtered solution in PBS, 200mM L-arginine (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
- State
- Lyophilized
- Storage Conditions
- -20 to -80°C for 12 months as supplied from date of receipt. -80°C for 3 months after reconstitution. Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Reconstitution Advice
- Dissolve the lyophilized protein in distilled water. Please refer to the Certificate of Analysis for detailed instructions.
Data Display
Biotinylated Human DLL3 Domain (311-492) on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Immobilized Biotinylated Human DLL3 (311-492), His-Avi tag at 0.5μg/ml (100μl/Well) on streptavidin (5μg/ml) precoated plate. Dose response curve for Anti-DLL3 Antibody, hFc Tag with the EC50 of 2.1ng/ml determined by ELISA. (QC Test)
Background
Delta-like protein 3 (DLL3) is a transmembrane protein that belongs to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands. DLL3 inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm (By similarity).
References
- Saunders L R, Bankovich A J, Anderson W C, et al. A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo[J]. Science Translational Medicine, 2015.
Have questions about this product?
Our technical team can help with product selection, application questions and order support.